Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00001085

Public ClinicalTrials.gov record NCT00001085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 6:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Phase II Study of 141W94 (VX-478) Monotherapy vs. 141W94 (VX-478) Plus ZDV Plus 3TC in HIV Infected Individuals

Study identification

NCT ID
NCT00001085
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
94 participants

Conditions and interventions

Conditions

Interventions

  • Amprenavir Drug
  • Lamivudine Drug
  • Zidovudine Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Aug 31, 1998
Last update posted
Nov 3, 2021

Ends 1998

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294
USC CRS Los Angeles California 900331079
University of Colorado Hospital CRS Aurora Colorado 80262
Univ. of Miami AIDS CRS Miami Florida 331361013
The Ponce de Leon Ctr. CRS Atlanta Georgia 30308
Northwestern University CRS Chicago Illinois 60611
Cook County Hosp. CORE Ctr. Chicago Illinois 60612
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Bmc Actg Crs Boston Massachusetts 02118
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts 02215
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri 63112
Washington U CRS St Louis Missouri
NY Univ. HIV/AIDS CRS New York New York 10016
Unc Aids Crs Chapel Hill North Carolina 275997215
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001085 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →